This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2019 Sep;16(9):514.

doi: 10.1038/s41575-019-0191-1.

CD11b agonism overcomes PDAC immunotherapy resistance

Affiliations

PMID: 31332304
DOI: 10.1038/s41575-019-0191-1

Comment

CD11b agonism overcomes PDAC immunotherapy resistance

Iain Dickson. Nat Rev Gastroenterol Hepatol. 2019 Sep.

. 2019 Sep;16(9):514.

doi: 10.1038/s41575-019-0191-1.

Author

Affiliation

¹ Nature Reviews Gastroenterology & Hepatology, . nrgasthep@springernature.com.

PMID: 31332304
DOI: 10.1038/s41575-019-0191-1

No abstract available

PubMed Disclaimer

Comment on

Agonism of CD11b reprograms innate immunity to sensitize pancreatic cancer to immunotherapies.
Panni RZ, Herndon JM, Zuo C, Hegde S, Hogg GD, Knolhoff BL, Breden MA, Li X, Krisnawan VE, Khan SQ, Schwarz JK, Rogers BE, Fields RC, Hawkins WG, Gupta V, DeNardo DG. Panni RZ, et al. Sci Transl Med. 2019 Jul 3;11(499):eaau9240. doi: 10.1126/scitranslmed.aau9240. Sci Transl Med. 2019. PMID: 31270275 Free PMC article.

References

Original article

1. Panni, R. Z. et al. Agonism of CD11b reprograms innate immunity to sensitize pancreatic cancer to immunotherapies. Sci. Transl. Med. 11, eaau9240 (2019) - DOI

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program